Infliximab shows potential in the treatment of corticosteroid-refractory acute GVHD

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1303, 2001-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment-refractory acute rejection of intestinal transplants may respond to infliximab

Inpharma, Vol. 1, Iss. 1410, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Novel Drugs for the Prevention and Treatment of Acute GVHD

Current Pharmaceutical Design, Vol. 14, Iss. 20, 2008-07 ,pp. : 1962-1973

Bentham Science Publishers

Access to resources Recommend Favorite

Troxacitabine administered as a continuous IV infusion shows "promising results" in the treatment of patients with refractory acute myeloid leukaemia

Inpharma, Vol. 1, Iss. 1575, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Pegvisomant shows potential in the treatment of acromegaly

Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Deferiprone shows potential in acute iron poisoning

Inpharma, Vol. 1, Iss. 1227, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite